These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37067430)

  • 21. A Proteasome Mutation Sensitizes
    Rosenthal MR; Ng CL
    ACS Infect Dis; 2021 Jul; 7(7):1923-1931. PubMed ID: 33971094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analysis of Plasmodium falciparum subpopulations associated with artemisinin resistance in Cambodia.
    Dwivedi A; Reynes C; Kuehn A; Roche DB; Khim N; Hebrard M; Milanesi S; Rivals E; Frutos R; Menard D; Mamoun CB; Colinge J; Cornillot E
    Malar J; 2017 Dec; 16(1):493. PubMed ID: 29258508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel Modulator of Ring Stage Translation (MRST) gene alters artemisinin sensitivity in
    Simmons C; Gibbons J; Wang C; Pires CV; Zhang M; Siddiqui F; Oberstaller J; Casandra D; Seyfang A; Cui L; Otto TD; Adams JH
    mSphere; 2023 Aug; 8(4):e0015223. PubMed ID: 37219373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border.
    Huang F; Shrestha B; Liu H; Tang LH; Zhou SS; Zhou XN; Takala-Harrison S; Ringwald P; Nyunt MM; Plowe CV
    Malar J; 2020 Sep; 19(1):334. PubMed ID: 32928233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-nucleotide polymorphisms of artemisinin resistance-related pfubp1 and pfap2mu genes in imported Plasmodium falciparum to Wuhan, China.
    Cheng W; Wu K; Song X; Wang W; Du W; Li J
    Infect Genet Evol; 2022 Jul; 101():105286. PubMed ID: 35470127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ring stage dormancy of Plasmodium falciparum tolerant to artemisinin and its analogues - A genetically regulated "Sleeping Beauty".
    Auparakkitanon S; Wilairat P
    Int J Parasitol Drugs Drug Resist; 2023 Apr; 21():61-64. PubMed ID: 36708651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A brief history of artemisinin: Modes of action and mechanisms of resistance.
    Lu F; He XL; Richard C; Cao J
    Chin J Nat Med; 2019 May; 17(5):331-336. PubMed ID: 31171267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure- and function-based design of Plasmodium-selective proteasome inhibitors.
    Li H; O'Donoghue AJ; van der Linden WA; Xie SC; Yoo E; Foe IT; Tilley L; Craik CS; da Fonseca PC; Bogyo M
    Nature; 2016 Feb; 530(7589):233-6. PubMed ID: 26863983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors.
    Hsu HC; Li D; Zhan W; Ye J; Liu YJ; Leung A; Qin J; Crespo B; Gamo FJ; Zhang H; Cui L; Roth A; Kirkman LA; Li H; Lin G
    Nat Commun; 2023 Dec; 14(1):8302. PubMed ID: 38097652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.
    Siddiqui FA; Boonhok R; Cabrera M; Mbenda HGN; Wang M; Min H; Liang X; Qin J; Zhu X; Miao J; Cao Y; Cui L
    mBio; 2020 Feb; 11(1):. PubMed ID: 32098812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome.
    Deni I; Stokes BH; Ward KE; Fairhurst KJ; Pasaje CFA; Yeo T; Akbar S; Park H; Muir R; Bick DS; Zhan W; Zhang H; Liu YJ; Ng CL; Kirkman LA; Almaliti J; Gould AE; Duffey M; O'Donoghue AJ; Uhlemann AC; Niles JC; da Fonseca PCA; Gerwick WH; Lin G; Bogyo M; Fidock DA
    Cell Chem Biol; 2023 May; 30(5):470-485.e6. PubMed ID: 36963402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined Transcriptome and Proteome Profiling for Role of pfEMP1 in Antimalarial Mechanism of Action of Dihydroartemisinin.
    Chen L; Zheng Z; Liu H; Wang X; Qu S; Yang Y; Deng S; Zhang Y; Tuo L; Zhao Y; Li Y
    Microbiol Spectr; 2021 Dec; 9(3):e0127821. PubMed ID: 34908430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
    Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
    Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Mechanisms of Drug Resistance in
    Wicht KJ; Mok S; Fidock DA
    Annu Rev Microbiol; 2020 Sep; 74():431-454. PubMed ID: 32905757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.
    Veiga MI; Ferreira PE; Jörnhagen L; Malmberg M; Kone A; Schmidt BA; Petzold M; Björkman A; Nosten F; Gil JP
    PLoS One; 2011; 6(5):e20212. PubMed ID: 21633513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The proteasome as a target to combat malaria: hits and misses.
    Krishnan KM; Williamson KC
    Transl Res; 2018 Aug; 198():40-47. PubMed ID: 30009761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic analysis of Indian isolates of Plasmodium falciparum: Implications for drug resistance and virulence factors.
    Choubey D; Deshmukh B; Rao AG; Kanyal A; Hati AK; Roy S; Karmodiya K
    Int J Parasitol Drugs Drug Resist; 2023 Aug; 22():52-60. PubMed ID: 37269630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimalarial drugs resistance genes of Plasmodium falciparum: a review.
    Tchekounou C; Zida A; Zongo C; Soulama I; Sawadogo PM; Guiguemde KT; Sangaré I; Guiguemde RT; Traore Y
    Ann Parasitol; 2022; 68(2):215-225. PubMed ID: 35809349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.